[Epidemiology of schizophrenia]
- PMID: 23678583
[Epidemiology of schizophrenia]
Abstract
Schizophrenia exhibits wide variation in epidemiological characteristics. Through the past few decades, we have learned much about schizophrenia epidemiology, providing important findings for etiological research, clinical care and public health. In this article, we provide overview of current research on incidence, prevalence, risk factors, mortality and outcome of schizophrenia. Contrary to traditional understanding, the incidence and prevalence of schizophrenia show prominent variation between locations. Risk factors for schizophrenia include urbanicity, migration, sex, season of birth and pregnancy and birth complications. Schizophrenia patients have an increased mortality risk compared with the general population. Recent studies about outcome show not so tragic, especially in regard to social functioning. Over the recent decades, circumstances have been changing around schizophrenia. As to treatment, for example, 'the second generation antipsychotics' have replaced conventional ones and 'early intervention' is developing. However, we have only limited evidences of current schizophrenia. Further epidemiological development is needed.
Similar articles
-
[Drawing up guidelines for the attendance of physical health of patients with severe mental illness].Encephale. 2009 Sep;35(4):330-9. doi: 10.1016/j.encep.2008.10.014. Epub 2009 Jul 9. Encephale. 2009. PMID: 19748369 French.
-
Schizophrenia: a concise overview of incidence, prevalence, and mortality.Epidemiol Rev. 2008;30:67-76. doi: 10.1093/epirev/mxn001. Epub 2008 May 14. Epidemiol Rev. 2008. PMID: 18480098 Review.
-
[Environmental risk factors for schizophrenia: a review].Encephale. 2013 Feb;39(1):19-28. doi: 10.1016/j.encep.2011.12.007. Epub 2012 Nov 21. Encephale. 2013. PMID: 23177330 Review. French.
-
Antipsychotic drugs and risk of type 2 diabetes: an evidence-based approach.Hum Psychopharmacol. 2004 Dec;19(8):549-58. doi: 10.1002/hup.628. Hum Psychopharmacol. 2004. PMID: 15378663 Review.
-
Atypical antipsychotic drugs, schizophrenia, and metabolic syndrome in non-Euro-American societies.Clin Neuropharmacol. 2012 May-Jun;35(3):141-7. doi: 10.1097/WNF.0b013e31824d5288. Clin Neuropharmacol. 2012. PMID: 22592510 Review.
Cited by
-
Alteration of gray matter microstructure in schizophrenia.Brain Imaging Behav. 2018 Feb;12(1):54-63. doi: 10.1007/s11682-016-9666-7. Brain Imaging Behav. 2018. PMID: 28102528 Free PMC article.
-
Association analysis of CHRNA3 polymorphisms with schizophrenia in a Chinese Han population: A case-control study.Medicine (Baltimore). 2018 Jun;97(23):e10863. doi: 10.1097/MD.0000000000010863. Medicine (Baltimore). 2018. PMID: 29879020 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous